REGULATE-PCI trial--Author's reply

Affiliations

¹ Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland, OH, USA. Electronic address: lincofa@ccf.org.
² Duke Clinical Research Institute, Duke Medicine, Durham, NC, USA.
³ Mount Sinai School of Medicine, New York, NY, USA.

Comment

A Michael Lincoff et al. Lancet. 2016.

. 2016 Apr 9;387(10027):1510-1511.

doi: 10.1016/S0140-6736(16)00694-2. Epub 2016 Apr 7.

¹ Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland, OH, USA. Electronic address: lincofa@ccf.org.
² Duke Clinical Research Institute, Duke Medicine, Durham, NC, USA.
³ Mount Sinai School of Medicine, New York, NY, USA.

No abstract available

Comment on

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
Lincoff AM, Mehran R, Povsic TJ, Zelenkofske SL, Huang Z, Armstrong PW, Steg PG, Bode C, Cohen MG, Buller C, Laanmets P, Valgimigli M, Marandi T, Fridrich V, Cantor WJ, Merkely B, Lopez-Sendon J, Cornel JH, Kasprzak JD, Aschermann M, Guetta V, Morais J, Sinnaeve PR, Huber K, Stables R, Sellers MA, Borgman M, Glenn L, Levinson AI, Lopes RD, Hasselblad V, Becker RC, Alexander JH; REGULATE-PCI Investigators. Lincoff AM, et al. Lancet. 2016 Jan 23;387(10016):349-356. doi: 10.1016/S0140-6736(15)00515-2. Epub 2015 Nov 5. Lancet. 2016. PMID: 26547100 Clinical Trial.
REGULATE-PCI trial.
Slade E, Hartley P, Heneghan C; COMPare project team. Slade E, et al. Lancet. 2016 Apr 9;387(10027):1510. doi: 10.1016/S0140-6736(16)30128-3. Epub 2016 Apr 7. Lancet. 2016. PMID: 27115976 No abstract available.